[Allergies--specific immunotherapy for rifampicin allergy].
D000328:Adult; D000368:Aged; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D002986:Clinical Trials as Topic; D003888:Desensitization, Immunologic / Q000379:methods; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis* / Q000276:immunology* / Q000628:therapy; D007108:Immune Tolerance / Q000187:drug effects; D007073:Immunoglobulin E / Q000097:blood; D007275:Injections, Intravenous; D007428:Intradermal Tests; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology*; D014581:Urticaria / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy
D000904:Antibiotics, Antitubercular; D007917:Leprostatic Agents; D007073:Immunoglobulin E; D012293:Rifampin